Gabapentin Capsule
Product Images NDC 43547-481

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 43547-481). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image01 (Image 01)

This text provides information about serum creatinine levels measured in mg/dL for male and female patients. The standard value is given as 0.72 for male patients, and it suggests multiplying by 0.35 for female patients.*

FDA Label Image

Image 02 Structural Formula (Image 02)

FDA Label Image

Image03 (Image 03)

Mean Pain Score for different treatments (Placebo and Gabapentin at 3600 mg/day) is provided over a 4-week Dose Titration Period followed by a 4-Week Fixed Dose Period. This data can be used to compare the effectiveness of the two treatments in managing pain.*

FDA Label Image

Image04 (Image 04)

This text appears to be a table showing a study design with a 3-week Dose Titration Period followed by a 4-week Fixed Dose Period. The study includes a placebo group and two Gabapentin dosage groups: 1800 mg/day and 2400 mg/day. It also references a "Mean Pain Score" with baseline and week data.*

FDA Label Image

Image05 (Image 05)

This text provides information on the proportion of responders in controlled PHN studies, specifically Study 1 and Study 2. It indicates the percentage reduction in pain score for patients with at least a 50% reduction. The data shows a higher proportion of responders in Study 1 (29%) compared to Study 2 (12-14%). It also includes details of the treatment groups such as placebo (PBO), and different doses of gabapentin (GBP). The statistical significance is denoted by the symbols #p<0.001 and %<0.0001.*

FDA Label Image

Image06 (Image 06)

FDA Label Image

100 mg (Image 07)

This text provides essential information about a medication called Gabapentin in capsule form. It includes instructions on proper storage conditions, dispensing requirements, dosage details, and manufacturing and distribution information. The medication contains 100 mg of gabapentin per capsule and is dispensed in child-resistant containers. For detailed prescribing information and medication guide, the package insert can be found at the website provided. The medication is manufactured by Zhejiang Huahai Pharmaceutical Technology in China and distributed by Solco Healthcare in the USA.*

FDA Label Image

300 mg (Image 08)

This is a description for a medication labeled as gabapentin capsules with a dosage of 300 mg per capsule. It is advised to store the medication at temperatures ranging from 20°C to 25°C, with excursions permitted between 15°C to 30°C. The capsules are to be dispensed in tight, child-resistant containers. The text includes information on the manufacturer, Zhejiang Huahai Pharmaceutical Technology Co., Ltd in China, and distribution by Solco Healthcare US, LLC in the USA. Extra resources such as the package insert and medication guide can be accessed online.*

FDA Label Image

400 mg (Image 09)

This text provides important information about storing gabapentin capsules, including the recommended temperature range and dispensing requirements. It also specifies the dosage, color additives, and manufacturing details. The text includes links for accessing the full prescribing information and medication guide online. Additionally, it mentions the distributor and quantity of capsules provided in each package.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.